Ospri specializes in PCR-based infectious disease detection and is financed by up to $30 million of strategic funding from Catalio Capital Management.

The submission releases $1.3 million in US funding support from the Biomedical Advanced Research and Development Authority (BARDA), the firm said.

Last week, readers were most interested in a story about WHO's update to its operational handbook for diagnosing tuberculosis.

TBI is a potential new application area for the 8-year-old company, while it continues to commercialize its stroke triage ...

The test is now authorized for use with anterior nasal swab samples in addition to the previously authorized throat and nasopharyngeal samples.

The technology can more effectively test for antibiotic susceptibility in heteroresistant bacterial populations than existing approaches.

The company's Acute Respiratory Distress and Pneumonia test is a PCR-based assay for the detection and differentiation of about 100 causes of infections.

The firm's goal for its SeekIt platform is to combine the accessibility of antibody and antigen testing and the accuracy of PCR for use in low-resource settings.

The firm said that it will use the money for working capital and general corporate purposes, and the raise follows a $3.25 million public offering that closed in May.

The US Food and Drug Administration granted clearances for PCR-based infectious disease tests from multiple entities as well as other in vitro diagnostic tests.

The firm performed 2,756 EsoGuard tests during the quarter and initiated testing and billing under its first commercial insurance coverage policy.

CHICAGO – Diasorin is poised to jump into the point-of-care molecular testing market next year with a compact benchtop instrument and a menu that will complement its lab-based testing systems. At the ...